Dopamine agonist monotherapy in early Parkinson's disease.
While levodopa therapy for Parkinson's disease is still considered the gold standard, motor complications are significant disadvantages of treatment. Monotherapy with dopamine agonists may present an alternative approach with a reduced likelihood of developing dyskinesias. Further studies are required before a definitive judgment can be made.
Clarke
C E
CE
Department of Neurology, City Hospital and University of Birmingham, Birmingham B18 7QH.
D002986:Clinical Trials as Topic; D003952:Diagnostic Imaging; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D018492:Dopamine Antagonists